Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 5,390.00
+290.00 (5.69%)
At close: Oct 1, 2026
| Market Cap | 266.73B +215.5% |
| Revenue (ttm) | 24.46B +1.8% |
| Net Income | -41.36B |
| EPS | -1,179.67 |
| Shares Out | 52.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 441,461 |
| Open | 5,110.00 |
| Previous Close | 5,100.00 |
| Day's Range | 5,000.00 - 5,420.00 |
| 52-Week Range | 2,585.00 - 10,180.00 |
| Beta | 0.38 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |